University of Wisconsin-Madison: Antivirals, some antibodies, work well against BA.2 omicron variant of COVID-19 virus - India Education Diary

The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.The BA.2 variant also re

The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizers Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the v… [+2616 chars]

full article...